Searchable abstracts of presentations at key conferences in endocrinology

ea0039oc5.8 | Oral Communications 5 | BSPED2015

Neonatal TSH: is it useful and appropriate as an indicator of iodine insufficiency in the UK?

Sharif Sahar , Jones Jeremy , Smith Sarah , Combet Emilie

Introduction: The World Health Organisation (WHO) states that in an iodine sufficient population <3% of neonatal TSH values will exceed 5 mU/l. In Belgium and Wales 2.6 and 1.5% of values were above 5 mU/l respectively.Methods: Neonatal TSH (neoTSH) levels (AutoDELFIA fluoroimmunoassay, 2006–2013, Scotland) were analysed for prevalence of high value according to cut-off, season and feeding mode (IBM SPSS 22).Results: Out o...

ea0030oc2.10 | Oral Communications 2 | BSPED2012

When is it justifiable to await venous thyroid function tests before starting thyroxine treatment in infants referred with capillary TSH elevation?

Pokrovska Tzveta , Jones Jeremy , Shaikh Guftar , Donaldson Malcolm

Background: In Scotland median age at notification with elevated capillary (c) TSH (>25 initially or >8 μ/l on repeat testing) is 10 (range 3–35) days. If cTSH elevation is >100 μ/l decompensated hypothyroidism (moderate: free (f) T4 5 −<10, severe: <5 pmol/l) is likely and thyroxine treatment should start without delay. If TSH elevation is mild the clinician may prefer to wait for venous (v) fT4 result and observe the infant’s pro...

ea0039ep120 | Thyroid | BSPED2015

Combined hypothyroidism and hypoparathyroidism in an infant following maternal administration of Iodine131 in early pregnancy

Sinka Sarita , Jones Jeremy , Staines Jonathan , Kinmond Sheena , Donaldson Malcom , Guftar Shaikh M

Background: In adults, hypoparathyroidism is a rare, but recognised complication of radioactive Iodine therapy. Hypothyroidism has been reported in neonates who have been exposed to Iodine131 in-utero, however, only one case of neonatal hypoparathyroidism secondary to maternal Iodine131 therapy has been described in the literature. To our knowledge this is the first case in the UK.Case presentation: A 27-year-old woman received two ...

ea0073aep105 | Calcium and Bone | ECE2021

Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: A new treatment strategy with Zoledronic Acid and Denosumab

Kilci Fatih , Demirsoy Ugur , Jones Jeremy H , Cizmecioglu-Jones Filiz Mine

IntroductionParaneoplastic hypercalcemia is extremely rare in the pediatric population, requiring urgent treatment. Pediatric malignancy-related hypercalcemia (PMRH) has been associated with rhabdomyosarcoma (RMS). Hypercalcemia with elevated parathyroid hormone (PTH), ectopic PTH secretion, is rarer (< 1% of cases). Reports of the use of Zoledronic Acid (ZA) as a second line bisphosphonate are limited. The monoclonal antibody, Denosumab, which inhib...

ea0039ep122 | Thyroid | BSPED2015

Scottish mothers and babies at Yorkhill (MABY) thyroid health study – preliminary report

Cizmecioglu Filiz Mine , Bouga Maira , Fletcher Suzanne , Sharif Sahar , Velasquez Guisella , Blaise Sarah , Jones Jeremy H , Donaldson Malcolm , Combet Emilie

Introduction: Iodine is essential for thyroid hormones synthesis, and fetal/infant neurodevelopment. There is increasing evidence of iodine insufficiency among British women. The MABY study is a longitudinal cohort study assessing the iodine and thyroid status of pregnant women and their offspring.Methods: Healthy women were recruited (target 697 mother/infant pairs) from antenatal clinics at gestational week (GW) 28±1. Blood and urine were collecte...